195 related articles for article (PubMed ID: 1253171)
21. Quantification by gas chromatography of N,N'-di-(2-chloroethyl)-phosphorodiamidic acid in the plasma of patients receiving isophosphamide.
Bryant BM; Jarman M; Baker MH; Smith IE; Smyth JF
Cancer Res; 1980 Dec; 40(12):4734-8. PubMed ID: 7438105
[TBL] [Abstract][Full Text] [Related]
22. Covalent sequestration of phosphoramide mustard by metallothionein--an in vitro study.
Wei D; Fabris D; Fenselau C
Drug Metab Dispos; 1999 Jul; 27(7):786-91. PubMed ID: 10383921
[TBL] [Abstract][Full Text] [Related]
23. DNA-binding products of nornitrogen mustard, a metabolite of cyclophosphamide.
Hemminki K
Chem Biol Interact; 1987 Jan; 61(1):75-88. PubMed ID: 3815587
[TBL] [Abstract][Full Text] [Related]
24. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
Low JE; Borch RF; Sladek NE
Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and structure-activity relationships of pre-activated analogs of cyclophosphamide (NSC-26271).
Montgomery JA; Struck RF
Cancer Treat Rep; 1976 Apr; 60(4):381-93. PubMed ID: 945126
[TBL] [Abstract][Full Text] [Related]
26. Reactions of nitrogen mustards with DNA.
Hemminki K; Kallama S
IARC Sci Publ; 1986; (78):55-70. PubMed ID: 3583398
[TBL] [Abstract][Full Text] [Related]
27. Bifunctional constructs of aspirin and ibuprofen (non-steroidal anti-inflammatory drugs; NSAIDs) that express antibacterial and alkylation activities.
Bartzatt R; Cirillo SL; Cirillo JD; Donigan L
Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):273-82. PubMed ID: 12533193
[TBL] [Abstract][Full Text] [Related]
28. N-(2-hydroxyethyl)-N-[2-(7-guaninyl)ethyl]amine, the putative major DNA adduct of cyclophosphamide in vitro and in vivo in the rat.
Benson AJ; Martin CN; Garner RC
Biochem Pharmacol; 1988 Aug; 37(15):2979-85. PubMed ID: 3395373
[TBL] [Abstract][Full Text] [Related]
29. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
Hales BF
Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of aromatic nitrogen mustard agents and analysis of their alkylation activity at physiological pH and temperature.
Bartzatt R; Kasher L
Physiol Chem Phys Med NMR; 2002; 34(2):103-17. PubMed ID: 12841328
[TBL] [Abstract][Full Text] [Related]
31. Aziridinium ion ring formation from nitrogen mustards: mechanistic insights from ab initio dynamics.
Mann DJ
J Phys Chem A; 2010 Apr; 114(13):4486-93. PubMed ID: 20222705
[TBL] [Abstract][Full Text] [Related]
32. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
Chang TK; Waxman DJ
Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
[TBL] [Abstract][Full Text] [Related]
33. Alkylation of guanosine and deoxyguanosine by phosphoramide mustard.
Mehta JR; Przybylski M; Ludlum DB
Cancer Res; 1980 Nov; 40(11):4183-6. PubMed ID: 7471059
[TBL] [Abstract][Full Text] [Related]
34. Half-life of oxazaphosphorines in biological fluids.
Sladek NE; Powers JF; Grage GM
Drug Metab Dispos; 1984; 12(5):553-9. PubMed ID: 6149904
[TBL] [Abstract][Full Text] [Related]
35. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
Thomas EA; Hsu HH; Griffin MT; Hunter AL; Luong T; Ehlert FJ
Mol Pharmacol; 1992 Apr; 41(4):718-26. PubMed ID: 1569923
[TBL] [Abstract][Full Text] [Related]
36. Plasma concentrations of 4-hydroxycyclophosphamide and phosphoramide mustard in patients repeatedly given high doses of cyclophosphamide in preparation for bone marrow transplantation.
Sladek NE; Doeden D; Powers JF; Krivit W
Cancer Treat Rep; 1984 Oct; 68(10):1247-54. PubMed ID: 6395951
[TBL] [Abstract][Full Text] [Related]
37. The pharmacokinetics of cyclophosphamide, phosphoramide mustard and nor-nitrogen mustard studied by gas chromatography in patients receiving cyclophosphamide therapy.
Juma FD; Rogers HJ; Trounce JR
Br J Clin Pharmacol; 1980 Oct; 10(4):327-35. PubMed ID: 7448105
[No Abstract] [Full Text] [Related]
38. Blood levels of alkylating metabolites of cyclophosphamide in the mouse after iv or oral administration.
Struck RF; Alberts DS
Cancer Treat Rep; 1984 May; 68(5):765-70. PubMed ID: 6722832
[TBL] [Abstract][Full Text] [Related]
39. Characterization of cyclophosphamide (NSC-26271) metabolites and related derivatives by field-desorption and electron-impact mass spectrometry.
Przybylski M; Ringsdorf H; Voelcker G; Draeger U; Peter G; Hohorst HJ
Cancer Treat Rep; 1976 Apr; 60(4):509-16. PubMed ID: 1277228
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of neutrophil chemotaxis by 4-hydroxycyclophosphamide.
Gilbert DN; Starr P; Eubanks N
Cancer Res; 1977 Feb; 37(2):456-9. PubMed ID: 832269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
